Tag Archive
Nanotech, Single-Molecule Methods, Personalized Medicine Remain Top of Mind for VCs (GenomeWeb News)
This is part two of a two-part series examining the venture capital landscape in the life science research tools and molecular diagnostics markets. To read part one, click here . (more…) Related items Nanobotmodels Company offer vision of future DNA and cell-repair techniques (News-Medical-Net) DNA nanotechnology breakthrough offers promising applications in medicine (EurekAlert!) Harness technology to reduce drug cost... »
CombiMatrix Corporation - Medical Equipment - Deals And Alliances Profile - New Report Published (OfficialWire)
CombiMatrix Corporation is a biotechnology company, with a subsidiary, CombiMatrix Molecular Diagnostics, Inc. (CMDX). The Company develops technologies, including products and services in the areas of drug development, genetic analysis, molecular diagnostics, nanotechnology and defense, and homeland security markets. (more…) Related items Nanotech Company Gets Fourth Federal Grant for Cleantech (PRWeb via Yahoo! News) Combimatrix Molecular Diagnostics Strengthens... »
Invitrogen, OGeS, Oxford University, Myriad Genetics, Abbott, Illumina, Genomics Collaborative, Cybridi, Third Wave … (GenomeWeb News)
Invitrogen, aiming to expand into the molecular diagnostics market, “welcomes” existing and impending competition from small, private shops, a company official said yesterday at BIO 2006, held in Chicago this week. (more…) Related items CombiMatrix Corporation - Medical Equipment - Deals And Alliances Profile - New Report Published (OfficialWire) Reportlinker Adds Global Nanobiotechnology Industry (PR Newswire via Yahoo!... »
Microchip That Can Detect Type And Severity Of Cancer Created By University Of Toronto Researchers (Medical News Today)
University of Toronto researchers have used nanomaterials to develop a microchip sensitive enough to quickly determine the type and severity of a patient’s cancer so that the disease can be detected earlier for more effective treatment. Their groundbreaking work, reported Sept. 27 in Nature Nanotechnology heralds an era when sophisticated molecular diagnostics will become... »
BioNanomatrix Appoints Genomic Research Experts Charles Lee and David L. Barker as Advisers (PR Newswire via Yahoo! Finance)
BioNanomatrix, Inc., a developer of breakthrough nanoscale technologies for biomedical research, molecular diagnostics and personalized medicine, today announced that Dr. Charles Lee and Dr. (read on…) Related items NHGRI grants BioNanomatrix $833,490 for commercial development of its NanoAnalyzer system (News-Medical-Net) NASA selects DNA Medicine Institute’s Nanoscale Diagnostics Technology for Phase II SBIR (SpaceRef) Metamaterials could reduce friction in nanomachines... »
